drugset / Trial / NCT03065309

Determination of Remifentanil's ED50 for Rapid Sequence Intubation Avoiding Bradycardia and Hypotension in Adults

NCT03065309

Phase 3 Completed 15 enrolled Brasilia University Hospital
SequentialOpen-labelSupportive care

Summary

This study will find the median effective dose of remifentanil for rapid sequence intubation which avoids bradycardia and hypotension

Timeline

Start
2017-02-25
Primary completion
2017-02-28
Completion
2017-03-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Remifentanil Small molecule

Indications